Altered mononuclear phagocyte differentiation associated with genetic defects of the lysosomal acid lipase

Atherosclerosis

Volumn 130, Issue 1-2, 1997, Pages 215-221

  Rothe, Gregor ^a   Stöhr, Josef ^a   Fehringer, Petra ^a   Gasche, Christoph ^b   Schmitz, Gerd ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

cholesteryl ester storage disease; lysosomal acid lipase; monocyte subpopulations; mononuclear phagocyte differentiation; Wolman disease

Indexed keywords

ADULT; ARTICLE; ATHEROSCLEROSIS; CHILD; CHOLESTEROL ESTER STORAGE DISEASE; CONTROLLED STUDY; HUMAN; MONOCYTE; PRIORITY JOURNAL; WOLMAN DISEASE;

ADOLESCENT; ADULT; ALLELES; ANTIGENS, CD14; ANTIGENS, CD56; ANTIGENS, DIFFERENTIATION; CHILD; CHILD, PRESCHOOL; CHOLESTEROL ESTER STORAGE DISEASE; CHOLESTEROL ESTERASE; FLOW CYTOMETRY; HUMANS; MIDDLE AGED; MONOCYTES; PEDIGREE; PHAGOCYTES; PHENOTYPE; POINT MUTATION; RECEPTORS, IGG; WOLMAN DISEASE;

EID: 0342684466     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)06065-6     Document Type: Article

References (35)

1. Ross R. Cell biology of atherosclerosis. Ann Rev Physiol 1995;57:791.
2. Van der Wal AC, Das PK, Tigges AJ, Becker AE. Macrophage differentiation in atherosclerosis. An in situ immunohistochemical analysis in humans. Am J Pathol 1992;141:161.
3. Averill LE, Meagher RC, Gerrity RG. Enhanced monocyte progenitor cell proliferation in bone marrow of hyperlipemic swine. Am J Pathol 1989;135:369.
4. Stragliotto E, Camera M, Postiglione A, Sirtori M, Di Minno G, Tremoli E. Functionally abnormal monocytes in hypercholesterolemia. Arterioscler Thromb 1993;13:944.
5. Hughes DA, Townsend PJ, Haslam PL. Enhancement of the antigen-presenting function of monocytes by cholesterol: possible relevance to inflammatory mechanisms in extrinsic allergic alveolitis and atherosclerosis. Clin Exp Immunol 1992;87:279.
6. Rothe G, Gabriel H, Kovacs E, Klucken J, Stöhr J, Kindermann W, Schmitz G. Peripheral blood mononuclear phagocyte subpopulations as cellular markers in hypercholesterolemia. Arterioscler Thromb Vasc Biol 1996;16:1437.
7. Passlick B, Flieger D, Ziegler-Heitbrock HWL. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 1989;74:2527.
8. Ziegler-Heitbrock HWL, Fingerle G, Ströbel M, Schraut W, Stelter F, Schütt C, Passlick B, Pforte A. The novel subset of CD14+/CD16+ blood monocytes exhibits features of tissue macrophages. Eur J Immunol 1993;23:2053.
9. Thomas R, Davis LS, Lipsky PE. Isolation and characterization of human peripheral blood dendritic cells. J Immunol 1993;150:821.
10. Thomas R, Lipsky PE. Human peripheral blood dendritic cell subsets. Isolation and characterization of precursor and mature antigen-presenting cells. J Immunol 1994;153:4016.
11. Dallongeville J, Lussier-Cacan S, Davignon J. Modulation of plasma triglyceride levels by apo E phenotype: a meta-analysis. J Lipid Res 1992;33:447.
12. Schwiegelshohn B, Presley JF, Gorecki M, Vogel T, Carpentier YA, Maxfield FR, Deckelbaum RJ. Effects of apoprotein E on intracellular metabolism of model triglyceride-rich particles are distinct from effects on cell particle uptake. J Biol Chem 1995;270:1761.
13. Choi SY, Komaromy MC, Chen J, Fong LG, Cooper AD. Acceleration of uptake of LDL but not chylomicron remnants by cells that secrete apo E and hepatic lipase. J Lipid Res 1994;35:848.
14. Goldstein JL, Brown MS. The low-density lipoprotein pathway and its relation to atherosclerosis. Ann Rev Biochem 1977;46:897.
15. Schmitz G, Assmann G. Acid lipase deficiency: Wolman disease and cholesteryl ester storage disease. In: Scriver CR, Beaudet AL, Sly WS and Valle D. (eds). The Metabolic Basis of Inherited Disease 6th edn New York:McGraw-Hill 1989:1623.
16. Anderson RA, Sando GN. Cloning and expression of cDNA encoding human lysosomal acid lipase/cholesteryl ester hydrolase. Similarities to gastric and lingual lipases. J Biol Chem 1991;266:22 479.
17. Aslanidis C, Klima H, Lackner KJ, Schmitz G. Genomic organization of the human lysosomal acid lipase gene (LIPA). Genomics 1994;20:329.
18. Anderson RA, Byrum RS, Coates PM, Sando GN. Mutations at the lysosomal acid cholesteryl ester hydrolase gene locus in Wolman disease. Proc Natl Acad Sci USA 1994;91:2718.
19. Klima H, Ullrich K, Aslanidis C, Fehringer P, Lackner KJ, Schmitz G. A splice junction mutation causes deletion of a 72-base exon from the mRNA for lysosomal acid lipase in a patient with cholesteryl ester storage disease. J Clin Invest 1993;92:2713.
20. Aslanidis C, Ries S, Fehringer P, Büchler C, Klima H, Schmitz G. Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity. Genomics 1996;33:85.
21. Ries S, Aslanidis C, Fehringer P, Carel J, Gendrel D, Schmitz G. A new mutation in the gene for lysosomal acid lipase leads to Wolman disease in an African kindred. J Lipid Res 1996;37:1761.
22. Aslanidis C, Ries S, Ameis D, Gasche C, Jung N, Schambach A, Fehringer P, Vanier MT, Schmitz G. Different missense mutations in histidine-108 of lysosomal acid lipase cause cholesteryl ester storage disease in unrelated compound heterozygous and hemizygous individuals. 1997; submitted for publication.
23. Haley NJ, Fowler S, De Duve C. Lysosomal acid cholesteryl esterase activity in normal and lipid-laden aortic cells. J Lipid Res 1980;21:961.
24. Wolman M. Wolman disease and its treatment. Clin Pediatr 1995;34:207.
25. Yatsu F, Hagemenas F, Manaugh L, Galumbos T. Cholesteryl ester hydrolase activity in human symptomatic atherosclerosis. Lipids 1980;15:1019.
26. Coates PM, Langer T, Cortner JA. Genetic variation of human mononuclear leukocyte lysosomal acid lipase activity. Relationship to atherosclerosis. Atherosclerosis 1986;62:11.
27. Hagemenas FC, Illingworth DR. Cholesterol homeostasis in mononuclear leukocytes from patients with familial hypercholesterolemia treated with lovastatin. Arteriosclerosis 1989;9:355.
28. Reuss-Borst MA, Steinke B, Waller HD, Bühring HJ, Müller CA. Phenotypic and clinical heterogeneity of CD56-positive acute nonlymphoblastic leukemia. Ann Hematol 1992;64:78.
29. Hurwitz CA, Raimondi SC, Head D, Krance R, Mirro Jr J, Kalwinsky DK, Ayers GD, Gehm FG. Distinctive immunophenotypic features of t(8;21)(q22;q22) acute myeloblastic leukemia in children. Blood 1992;80:3182.
30. Lanza F, Bi S, Castoldi G, Goldman JM. Abnormal expression of N-CAM (CD56) adhesion molecule on myeloid and progenitor cells from chronic myeloid leukemia. Leukemia 1993;7:1570.
31. Fingerle G, Pforte A, Passlick B, Blumenstein M, Ströbel M, Ziegler-Heitbrock HWL. The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients. Blood 1993;82:3170.
32. Allen JB, Wong HL, Guyre PM, Simon Gl, Wahl SM. Association of circulating receptor FeγRIII positive monocytes in AIDS patients with elevated levels of transforming growth factor-β. J Clin Invest 1991;87:1773.
33. Locher C, Vanham G, Kestens L, Kruger M, Ceuppens JL, Vingerhoets J. Expression patterns of Fcγ receptors, HLA-DR and selected adhesion molecules on monocytes from normal and HIV-infected individuals. Clin Exp Immunol 1994;98:115.
34. Saleh MN, Goldman SJ, LoBuglio AF, Beall AC, Sabio H, McCord MC, Minasian L, Alpaugh RK, Weiner LM, Munn DH. CD16+ monocytes in patients with cancer: spontaneous elevation and pharmacologic induction by recombinant human macrophage colony-stimulating factor. Blood 1995;85:2910.
35. Weiner LM, Li W, Holmes M, Catalano RB, Dovnarsky M, Padavic K, Alpaugh RK. Phase I trial of recombinant macrophage colony-stimulating factor and recombinant γ-interferon: toxicity, monocytosis, and clinical effects. Cancer Res 1994;54:4084.